Ignite Creation Date:
2024-05-05 @ 11:29 AM
Last Modification Date:
2024-10-26 @ 9:08 AM
Study NCT ID:
NCT00055198
Status:
TERMINATED
Last Update Posted:
2017-06-14
First Post:
2003-02-20
Brief Title:
Daptomycin for the Treatment of Infections Due to Gram-Positive Bacteria
Sponsor:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA
Organization:
Cubist Pharmaceuticals LLC a subsidiary of Merck Co Inc Rahway New Jersey USA